MXPA99004944A - Antagonistas de somatostatina. - Google Patents

Antagonistas de somatostatina.

Info

Publication number
MXPA99004944A
MXPA99004944A MXPA99004944A MX9904944A MXPA99004944A MX PA99004944 A MXPA99004944 A MX PA99004944A MX PA99004944 A MXPA99004944 A MX PA99004944A MX 9904944 A MX9904944 A MX 9904944A MX PA99004944 A MXPA99004944 A MX PA99004944A
Authority
MX
Mexico
Prior art keywords
somatostatin antagonists
antagonists
somatostatin
residue
amino acid
Prior art date
Application number
MXPA99004944A
Other languages
English (en)
Inventor
William Murphy
Original Assignee
Conseils De Rech S Et Soc D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/855,204 external-priority patent/US6262229B1/en
Application filed by Conseils De Rech S Et Soc D filed Critical Conseils De Rech S Et Soc D
Publication of MXPA99004944A publication Critical patent/MXPA99004944A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invencion esta caracterizada por antagonistas de somatostatina que tienen un aminoacido D en el segundo residuo.
MXPA99004944A 1996-12-04 1997-12-04 Antagonistas de somatostatina. MXPA99004944A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3235896P 1996-12-04 1996-12-04
US76067296A 1996-12-04 1996-12-04
US08/855,204 US6262229B1 (en) 1996-12-04 1997-05-13 Somatostatin antagonists
PCT/US1997/022251 WO1998024807A2 (en) 1996-12-04 1997-12-04 Somatostatin antagonists

Publications (1)

Publication Number Publication Date
MXPA99004944A true MXPA99004944A (es) 2004-09-10

Family

ID=27364103

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA99004944A MXPA99004944A (es) 1996-12-04 1997-12-04 Antagonistas de somatostatina.

Country Status (17)

Country Link
EP (1) EP0956296B1 (es)
JP (2) JP4124820B2 (es)
KR (1) KR100479149B1 (es)
AT (1) ATE330966T1 (es)
AU (1) AU728224B2 (es)
BR (1) BR9714376A (es)
CA (1) CA2274144C (es)
DE (1) DE69736193T2 (es)
ES (1) ES2264174T3 (es)
HU (1) HUP0003396A3 (es)
IL (1) IL130166A0 (es)
MX (1) MXPA99004944A (es)
NZ (1) NZ335879A (es)
PL (1) PL334089A1 (es)
RU (1) RU2179172C2 (es)
TW (1) TW575582B (es)
WO (1) WO1998024807A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01013127A (es) * 1999-06-25 2002-11-04 Sod Conseils Rech Applic Agonistas de somatostatina.
US6864234B1 (en) 1999-06-25 2005-03-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Somatostatin agonists
AU2002258465B2 (en) * 2001-03-08 2006-01-19 The Administrators Of The Tulane Educational Fund Somatostatin antagonists
AU2002256105B2 (en) * 2001-04-09 2006-04-06 The Administrators Of The Tulane Educational Fund Somatostatin agonists
US8691761B2 (en) 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
SI2076535T1 (sl) 2006-10-16 2013-07-31 The Salk Institute For Biological Studies Antagonisti somatostatina, selektivni za receptor (SSTR2)
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
WO2011151782A1 (en) 2010-06-02 2011-12-08 Preglem Sa A role for somatostatin to modulate initiation of follicular growth in the human ovary
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
WO1990012811A1 (en) * 1989-04-26 1990-11-01 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin

Also Published As

Publication number Publication date
WO1998024807A2 (en) 1998-06-11
HUP0003396A3 (en) 2001-03-28
DE69736193D1 (de) 2006-08-03
KR20000069243A (ko) 2000-11-25
JP2001505580A (ja) 2001-04-24
JP4264762B2 (ja) 2009-05-20
EP0956296B1 (en) 2006-06-21
NZ335879A (en) 2000-11-24
RU2179172C2 (ru) 2002-02-10
HUP0003396A1 (hu) 2001-02-28
TW575582B (en) 2004-02-11
AU728224B2 (en) 2001-01-04
JP2008120818A (ja) 2008-05-29
DE69736193T2 (de) 2007-05-03
KR100479149B1 (ko) 2005-03-25
PL334089A1 (en) 2000-01-31
ES2264174T3 (es) 2006-12-16
AU7624898A (en) 1998-06-29
WO1998024807A3 (en) 1998-10-15
ATE330966T1 (de) 2006-07-15
JP4124820B2 (ja) 2008-07-23
BR9714376A (pt) 2000-03-21
EP0956296A2 (en) 1999-11-17
CA2274144C (en) 2004-03-30
IL130166A0 (en) 2000-06-01
CA2274144A1 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
ZA9710518B (en) Oxytocin heptapeptide analogues.
ZA972570B (en) Cement additives.
YU15299A (sh) Farmaceutski sastavi
EP0670413A3 (en) Quick connector for cementing head.
EP1023061A4 (en) SOMATOSTATIN AGONISTS
EP0977751A4 (en) SOMATOSTATIN AGONISTS
ZA974234B (en) Adhesion receptor antagonists.
EP0984779A4 (en) STOMATOSTATIN AGONISTS
ZA974147B (en) Somatostatin agonists and antagonists.
ZA986358B (en) Dolastatin 15 derivatives.
WO1997030082A3 (fr) Peptide antibacterien et antifongique
ZA9810685B (en) Thrombin receptor antagonists.
IL130166A0 (en) Somatostatin antagonists
IL134728A0 (en) Fibrinogen-based tissue adhesive
ZA974333B (en) Beta-lactams.
EP1082126A4 (en) NEW PEPTIDES
ZA956812B (en) Excitatory amino acid receptor antagonists.
HK1019082A1 (en) Excavating tool.
PL335369A1 (en) Acarbosic claster from actinoplanes sp. se 50/110
HK1014964A1 (en) Somatostatin peptides.
GB2325466A (en) Nucleotide sequence from goat liver
ZA981891B (en) Peptides useful as somatostatin antagonists.
ZA9710855B (en) Somatostatin antagonists.
NZ314277A (en) Octopeptide somatostatin antagonist
ZA983685B (en) Pregnanes.